Surgical Site Infection (SSIS) remains one of the most frequent and impactful complications following Cesarean Section (cs), with global incidence rates ranging from 3-20% and associated maternal morbidity and mortality reaching up to 3%. In this retrospective hospital based study conducted at George town public hospital corporation, 703 patient charts were reviewed, of which 51 met the inclusion criteria for analysis using the Statistician Package For Social Sciences (SPSS). The prevalence of skin after CS was found to be 7.3%, indicating that postoperative ingectuons continue to pose a significant clinical concern. The majority of cases (96.1%) were classified as class I SSI, while 3.9% were class ii, and no instances of organ space infection were identified. The mean age of affected patients was 27.5 years, highlighting a predominace among young women in their reproductive prime. Obesity emerged as the most common comorbidity, present in 68.8% of cases, underscoring its role as a major modifiable risk factor. The study also demonstrate an elevates SSI rate of 17.6% among patients which experienced Rupture of Member (ROM) prior to CS; notably, prolonged rom exceeding 18 hours was recorded in 13.7% of cases, compared to 3.9% with rom under 18 hours. Additional associated conditions included anemia, postpartum hemorrhage, each contributing 2% the clinical profile. Microbiology analysis revealed staphylococcus aureus as the most frequent isolated pathogen, followed by escheria coli, klebsiella pneumonia, and methicillin resistant staphylococcu aureus (MRSA). These findings emphasize that despite advances in surgical technique and infection to control SSIS following cesarean delivery continue to present a substantial burden. Therefore, targeted interventions aimed at reducing preventable risk factors especially obesity, prolonged rom, and other modifiable maternal conditions are essential for improving postoperative outcomes and minimizing the overall impact of SSIS on maternal health.

Oleta Onicka Pluck is a Guyanese medical doctor with substantive experience in clinical medicine and Preclinical medical education. She earned her Doctor of Medicine (MD) Degree for Georgetown American University School of Medicine in November 2019. She subsequently completed her one-year medical internship at the Georgetown Public Hospital Corporation from 2021-2022, where she obtained comprehensive clinical training across core medical and surgical disciplines. In 2022, she assumed the position of Head of Department of Preclinical Sciences at Georgetown American University School of Medicine. In this capacity, she was responsible for academic oversight, curriculum delivery and the evaluation of students competencies. She also served as a lecturer in pharmacology, contributing to the development of medical students through structured teaching and academic mentorship. From January 2024 to December 2024; she served a General Medical Practitioner at the Linden Hospital Complex during this tenure, she provided direct patient care, managed diverse clinical presentations, and practice within a multidisciplinary healthcare environment. Dr. Pluck’s professional interests includes clinical medicine, medical education and research aimed at improving healthcare delivery and patient outcomes.